373-49-9
Product Name:
PALMITOLEIC ACID
Formula:
C16H30O2
Synonyms:
cis-9-Hexadecenoic acid;cis-9-Palmitoleic acid
Inquiry
CHEMICAL AND PHYSICAL PROPERTIES
Physical Description | Liquid |
---|---|
Melting Point | -0.1 °C |
Collision Cross Section | 167.47 Ų [M-H]- [CCS Type: DT; Buffer gas: N2; Sample Type: Human bronchoalveolar lavage fluid (BALF); Dataset: Unambiguous Lipids] |
Kovats Retention Index | 1930 1930 1929 1931 1942 1936 1936 1945 1936 1931 1933 1947 1957 1939 1939 |
Chemical Classes | Lipids -> Unambiguous Lipids |
SAFETY INFORMATION
Signal word | Warning |
---|---|
Pictogram(s) |
Exclamation Mark Irritant GHS07 |
GHS Hazard Statements |
H315:Skin corrosion/irritation H319:Serious eye damage/eye irritation H335:Specific target organ toxicity, single exposure;Respiratory tract irritation H413:Hazardous to the aquatic environment, long-term hazard |
Precautionary Statement Codes |
P261:Avoid breathing dust/fume/gas/mist/vapours/spray. P264:Wash hands thoroughly after handling. P264:Wash skin thouroughly after handling. P271:Use only outdoors or in a well-ventilated area. P273:Avoid release to the environment. P302+P352:IF ON SKIN: wash with plenty of soap and water. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing. |
COMPUTED DESCRIPTORS
Molecular Weight | 254.41 g/mol |
---|---|
XLogP3 | 6.4 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 13 |
Exact Mass | 254.224580195 g/mol |
Monoisotopic Mass | 254.224580195 g/mol |
Topological Polar Surface Area | 37.3 Ų |
Heavy Atom Count | 18 |
Formal Charge | 0 |
Complexity | 209 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently-Bonded Unit Count | 1 |
Compound Is Canonicalized | Yes |
PRODUCT INTRODUCTION
description
Palmitoleic acid is a hexadec-9-enoic acid in which the double bond at position C-9 has cis configuration. It has a role as an EC 3.1.1.1 (carboxylesterase) inhibitor, a Daphnia galeata metabolite, a human blood serum metabolite, an algal metabolite and an Escherichia coli metabolite. It is a conjugate acid of a palmitoleate.